Roskelley, C. D., Srebrow, A. & Bissell, M. J. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr. Opin. Cell Biol.7, 736–747 (1995). ArticleCASPubMedPubMed Central Google Scholar
Schwartz, M. A. & Baron, V. Interactions between mitogenic stimuli, or, a thousand and one connections. Curr. Opin. Cell Biol.11, 197–202 (1999). ArticleCASPubMed Google Scholar
Radisky, D., Muschler, J. & Bissell, M. J. Order and disorder: the role of extracellular matrix in epithelial cancer. Cancer Invest. (in the press).
Kumar, N. M. and Gilula, N. B. The gap junction communication channel. Cell84, 381–388 (1996). ArticleCASPubMed Google Scholar
Green, K. J. & Gaudry, C. A. Are desmosomes more than tethers for intermediate filaments? Nature Rev. Mol. Cell. Biol.1, 208–216 (2000). ArticleCAS Google Scholar
Tsukita, S., Furuse, M. and Itoh, M. Multifunctional strands in tight junctions. Nature Rev. Mol. Cell. Biol.2, 285–293 (2001). ArticleCAS Google Scholar
Runswick, S. K., O'Hare, M. J., Jones, L., Streuli, C. H. & Garrod, D. R. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nature Cell Biol.3, 823—830 (2001). ArticleCASPubMed Google Scholar
Christofori, G. & Semb, H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci.24, 73–76 (1999). ArticleCASPubMed Google Scholar
Raghavan, S., Bauer, C., Mundschau, G., Li, Q. & Fuchs, E. Conditional ablation of β1 integrin in skin. Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination. J. Cell Biol.150, 1149–1160 (2000). ArticleCASPubMedPubMed Central Google Scholar
Lochter, A. et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J. Cell Biol.139, 1861–1872 (1997). ArticleCASPubMedPubMed Central Google Scholar
Hordijk, P. L. et al. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science278, 1464–1466 (1997). ArticleCASPubMed Google Scholar
Perl, A. K., Wilgenbus, P., Dahl, U., Semb, H. & Christofori, G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature392, 190–193 (1998).Using E-cadherin knockout mice and dominant-negative forms of this protein, the authors show that loss of E-cadherin is associated with pancreatic β-cell carcinogenesis. ArticleCASPubMed Google Scholar
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L. & Aaronson, S. A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol.148, 779–790 (2000). ArticleCASPubMedPubMed Central Google Scholar
Auersperg, N. et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc. Natl Acad. Sci. USA96, 6249–6254 (1999). ArticleCASPubMedPubMed Central Google Scholar
Nicholson, B. J., Weber, P. A., Cao, F., Chang, H., Lampe, P. & Goldberg, G. The molecular basis of selective permeability of connexins is complex and includes both size and charge. Braz. J. Med. Biol. Res.33, 369–378 (2000). ArticleCASPubMed Google Scholar
Hanna, E. A. et al. Gap juncitonal intercellular communication and connexin43 expression in human ovarian surface epithelial cells and ovarian carcinomas in vivo and in vitro. Carcinogenesis20, 1369–1373 (1999). ArticleCASPubMed Google Scholar
Locke, D. Gap junctions in normal and neoplastic mammary gland. J. Pathol.186, 343–349 (1998). ArticleCASPubMed Google Scholar
Saunders, M. M. et al. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res.61, 1765–1767 (2001). CASPubMed Google Scholar
Temme, A. et al. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin 32. Curr. Biol.7, 713–716 (1997). ArticleCASPubMed Google Scholar
Moennikes, O., Buchmann, A., Willecke, K., Traub, O. & Schwarz, M. Hepatocarcinogenesis in female mice with mosaic expression of connexin32. Hepatology32, 501–506 (2000). ArticleCASPubMed Google Scholar
Zhang, Z. Q. et al. Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43. Carcinogenesis19, 1889–1894 (1998). ArticleCASPubMed Google Scholar
King, T. J. et al. Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression. Carcinogenesis21, 1097–1109 (2000). ArticleCASPubMed Google Scholar
Krutovskikh, V. A. et al. Differential effect of subcellular communication impairing gap junction protein connexin43 on tumor cell grown in vivo. Oncogene19, 505–513 (2000). ArticleCASPubMed Google Scholar
Mesnil, M. et al. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res.55, 629–639 (1995). CASPubMed Google Scholar
Ito, A. et al. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest.105, 1189–1197 (2000). ArticleCASPubMedPubMed Central Google Scholar
Ronnov-Jessen, L., Petersen, O. W. & Bissell, M. J. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol. Rev.76, 69–125 (1996). ArticleCASPubMed Google Scholar
Sternlicht, M. D., Kedeshian, P., Shoa, Z. M., Safarians, S. & Barsky, S. H. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res.3, 1949–1958 (1997). CASPubMed Google Scholar
Stoler, D. L. et al. The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc. Natl Acad. Sci. USA96, 15121–15126 (1999). ArticleCASPubMedPubMed Central Google Scholar
Frame, S. & Balmain, A. Integration of positive and negative growth signals during Ras pathway activation in vivo. Curr. Opin. Genet. Dev.10, 106–113 (2000). ArticleCASPubMed Google Scholar
Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D. & Smith, H. S. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science274, 2057–2059 (1996). ArticleCASPubMed Google Scholar
Washington, C., Dalbègue, F., Abreo, F., Taubenberger, J. K. & Lichy, J. H. Loss of heterozygosity in fibrocystic change of the breast. Am. J. Pathol.157, 323–329 (2000). ArticleCASPubMedPubMed Central Google Scholar
Bissell, M. J. et al. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Res.59, 1757–1763 (1999). CASPubMed Google Scholar
Sieweke, M. H. & Bissell, M. J. The tumor-promoting effect of wounding: a possible role for TGF-β-induced stromal alterations. Crit. Rev. Oncog.5, 297–311 (1994). ArticleCASPubMed Google Scholar
Dolberg, D. S., Hollingsworth, R., Hertle, M. & Bissell, M. J. Wounding and its role in RSV-mediated tumor formation. Science230, 676–678 (1985). ArticleCASPubMed Google Scholar
Sieweke, M. H., Thompson, N. L., Sporn, M. B. & Bissell, M. J. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science248, 1656–1660 (1990). ArticleCASPubMed Google Scholar
Barcellos-Hoff, M. H. & Ravani, S. A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res.60, 1254–1260 (2000).Radiation-induced mutation of the stromal microenvironment can contribute to neoplastic progression of epithelial cellsin vivo, indicating that disruption of solid tissue interactions is a method by which ionizing radiation acts as a carcinogen. CASPubMed Google Scholar
Ehrhart, E. J., Segarini, P., Tsang, M. L., Carroll, A. G. & Barcellos-Hoff, M. H. Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose γ-irradiation. FASEB J.11, 991–1002 (1997). ArticleCASPubMed Google Scholar
Moinfar, F. et al. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res.60, 2562–2566 (2000).An examination of loss of heterozygosity (LOH) in microdissected mammary stromal and epithelial tissue samples. LOH at several loci was observed exclusively in stromal cells, indicating that genetic instability in the stroma can be a contributing factor to tumour progression. CASPubMed Google Scholar
Jacoby, R. F. et al. A juvenile polyposis tumor suppressor locus at 10p11 is deleted from nonepithelial cells in the lamina propria. Gastroenterology112, 1398–1403 (1997). ArticleCASPubMed Google Scholar
Howe, J. R. et al. Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science280, 1086–1088 (1998).Alterations in stromal function predispose colonic epithelial cells to carcinoma. ArticleCASPubMed Google Scholar
Thomasset, N. et al. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development. Am. J. Pathol.153, 457–467 (1998). ArticleCASPubMedPubMed Central Google Scholar
Tlsty, T. D. Stromal cells can contribute oncogenic signals. Semin. Cancer Biol.11, 97–104 (2001). ArticleCASPubMed Google Scholar
Vu, T. H. & Werb, Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev.14, 2123–2133 (2000). ArticleCASPubMed Google Scholar
Sethi, T. et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nature Med.5, 662–668 (1999). ArticleCASPubMed Google Scholar
Mitsiades, N., Yu, W., Poulaki, V., Tsokos, M. & Stamenkovic, I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res.61, 577–581 (2001). CASPubMed Google Scholar
Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev.14, 163–176 (2000). ArticlePubMedPubMed Central Google Scholar
Sternlicht, M. D. et al. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell98, 137–146 (1999).Shows that sustained expression of stromelysin-1, a stromal enzyme that destroys the basement membrane, can lead to epithelial tumorigenesis. ArticleCASPubMedPubMed Central Google Scholar
Wright, J. et al. A switch from stromal to tumor cell expression of stromelysin-1 mRNA is associated with the conversion of squamous to spindle cell carcinomas during mouse skin tumor progression. Mol Carcinog10, 207–215 (1994). ArticleCASPubMed Google Scholar
Boudreau, N., Sympson, C. J., Werb, Z. & Bissell, M. J. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science267, 891–893 (1995). ArticleCASPubMedPubMed Central Google Scholar
Sympson, C. J. et al. Targeted expression of stromelysin-1 in mammary gland provides evidence for proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J. Cell Biol.125, 681–693 (1994). ArticleCASPubMed Google Scholar
Witty, J. P., Wright, J. H. & Matrisian, L. M. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol. Biol. Cell.6, 1287–1303 (1995). ArticleCASPubMedPubMed Central Google Scholar
Rudolph-Owen, L. A., Chan, R., Muller, W. J. & Matrisian, L. M. The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res.58, 5500–5506 (1998). CASPubMed Google Scholar
Boulay, A. et al. High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase. Cancer Res.61, 2189–2193 (2001). CASPubMed Google Scholar
Ha, H.-Y. et al. Overexpression of membrane-type matrix metalloproteinase-1 induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res.61, 984–990 (2001). CASPubMed Google Scholar
Kaplan, D. H. et al. Demonstration of an interferon-γ-dependent tumor surveillance system in immunocompromised mice. Proc. Natl Acad. Sci. USA95, 7556–7561 (1998). ArticleCASPubMedPubMed Central Google Scholar
Nakajima, C. et al. A role of interferon-γ (IFN-γ) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-γ-deficient mice. Cancer Res.61, 3399–3405 (2001). CASPubMed Google Scholar
Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature410, 1107–1111 (2001). ArticleCASPubMed Google Scholar
Beatty, G. L. & Paterson, Y. IFN-γ-dependent inhibition of tumor angiogenesis by tumor angiogenesis of tumor-infiltrating CD4+ T cells requires tumor responsiveness to IFN-γ. J. Immunol.166, 2276–2282 (2001). ArticleCASPubMed Google Scholar
Hanson, H. L. et al. Eradication of established tumors by CD8+ T cell adoptive immunotherapy. Immunity13, 265–276 (2000). ArticleCASPubMed Google Scholar
Griffith, T. S. et al. Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL. J. Exp. Med.189, 1343–1353 (1999). ArticleCASPubMedPubMed Central Google Scholar
Smyth, M. J. et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon-γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med.193, 661–670 (2001). ArticleCASPubMedPubMed Central Google Scholar
Maria, D. A. et al. Resistance to melanoma metastases in mice selected for high acute inflammatory response. Carcinogenesis22, 337–342 (2001). ArticleCASPubMed Google Scholar
Beatty, G. L. & Paterson, Y. IFN-γ can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J. Immunol.165, 5502–5508 (2000). ArticleCASPubMed Google Scholar
Gati, A. et al. Tumor cells regulate the lytic activity of tumor-specific cytotoxic T lymphocytes by modulating the inhibitory natural killer receptor function. Cancer Res.61, 3240–3244 (2001). CASPubMed Google Scholar
Ganss, R. and Hanahan, D. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res.58, 4673–4681 (1998). CASPubMed Google Scholar
Wei, W. Z., Fulton, A., Winkelhake, J. and Heppner, G. Correlation of natural killer activity with tumorigenesis of a preneoplastic mouse mammary lesion. Cancer Res.49, 2709–2715 (1989). CASPubMed Google Scholar
Coussens, L. M. et al. Inflammatory mast cells upregulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev.13, 1382–1397 (1999). ArticleCASPubMedPubMed Central Google Scholar
Coussens, L. M., Tinkle, C. L., Hanahan, D. & Werb, Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell103, 481–490 (2000).References70and71showed that mast cells secrete MMP-9 following infiltration of developing squamous epithelial tumours, and that this action stimulates both development of malignancy and subsequent angiogenesis. ArticleCASPubMedPubMed Central Google Scholar
Bergers, B. et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol.2, 737–744 (2000). ArticleCASPubMed Google Scholar
Lin, E. Y., Nguyen, A. V., Russell, R. G. & Pollard, J. W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med.193, 727–739 (2001).Showed that macrophages potentiate neoplastic progression through paracrine factors, indicating that these factors are important to tumorigenesis as genetic mutations. ArticleCASPubMedPubMed Central Google Scholar
Fang, K. C. et al. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-β. J. Immunol.162, 5528–5535 (1999). CASPubMed Google Scholar
Frank, B. T., Rossall, J. C., Caughey, G. H. & Fang, K. C. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by α-chymase. J. Immunol.166, 2783–2792 (2001). ArticleCASPubMed Google Scholar
Mitchell, R. A. & Bucala, R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin. Cancer Biol.10, 359–366 (2000). ArticleCASPubMed Google Scholar
Abe, R., Peng, T., Sailors, J., Bucala, R. & Metz, C. N. Regulation of the CTL response by macrophage migration inhibitory factor. J. Immunol.166, 747–753 (2001). ArticleCASPubMed Google Scholar
Hudson, J. D. et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med.190, 1375–1382 (1999).Macrophage inhibitory factor (MIF) suppress p53-dependent transcriptional activity and blocks senescence of primary mouse embryonic fibroblasts. ArticleCASPubMedPubMed Central Google Scholar
Shao, C. et al. Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc. Natl Acad. Sci. USA97, 7405–7410 (2000). ArticleCASPubMedPubMed Central Google Scholar
Maniotis, A. J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol.155, 739–752 (1999).Microscopic sectioning of uveal (ocular) tumours provided the first evidence that, in addition to directing the behaviour of stromal endothelium, tumours might also develop into functional channels capable of connencting to host vasculature. ArticleCASPubMedPubMed Central Google Scholar
Chang, Y. S. et al. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl Acad. Sci. USA97, 14608–14613 (2000). ArticleCASPubMedPubMed Central Google Scholar
Shirikawa, K. et al. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res.61, 445–451 (2001). Google Scholar
Hendrix, M. J. C. et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl Acad. Sci. USA98, 8018–8023 (2001). ArticleCASPubMedPubMed Central Google Scholar
Forberg, R., Hendrix, M. J. C. & Maniotis, A. J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol.156, 361–381 (2000). Article Google Scholar
Akashi, K., Reya, T., Dalma-Weiszhausz, D. & Weissman, I. L. Lympoid precursors. Curr. Opin. Immunol.12, 144–150 (2000). ArticleCASPubMed Google Scholar
Khan, A. A., Bose, C., Yam, L. S., Soloski, M. J. & Rupp, F. Physiological regulation of the immunological synapse by agrin. Science292, 1681–1686 (2001). ArticleCASPubMed Google Scholar
Yang, F.-C. et al. Rac and Cdc42 GTPases control hematopoietic stem cell shape, adhesion, migration, and mobilization. Proc. Natl Acad. Sci. USA98, 5614–5618 (2001). ArticleCASPubMedPubMed Central Google Scholar
Dror, Y. & Freedman, M. H. Schwachman–Diamond syndrome: an inherited preleukemic bone marrow failure disorder with aberrant hematopoietic progenitors and faulty marrow microenvironment. Blood94, 3048–3054 (1999). ArticleCASPubMed Google Scholar
Damiano, J. S., Cress, A. E., Hazelhurst, L. A., Shtil, A. A. & Dalton, W. S. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood93, 1658–1667 (1999). ArticleCASPubMed Google Scholar
Aziz, K. A., Till, K. J., Zuzel, M. & Cawley, J. C. Involvement of CD44–hyaluronan interaction in malignant cell homing and fibronectin synthesis in hairy cell leukemia. Blood96, 3161–3167 (2000). ArticleCASPubMed Google Scholar
Børset, M., Hjertner, Ø., Yaccoby, S., Epstein, J. & Sanderson, R. D. Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins. Blood96, 2528–2536 (2000). ArticlePubMed Google Scholar
Barillé, S. et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of pro-MMP-2, and induction of MMP-1 by myeloma cells. Blood90, 1649–1655 (1997). ArticlePubMed Google Scholar
Kossakowska, A. E. et al. Interleukin-6 regulation of matrix-metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas. Blood94, 2080–2089 (1999). ArticleCASPubMed Google Scholar
Michigami, T. et al. Cell–cell contact between marrow stromal cells and myeloma cells via VCAM-1 and α4β1-integrin enhances production of osteoclast-stimulating activity. Blood96, 1953–1960 (2000). ArticleCASPubMed Google Scholar
Sanz-Rodríguez, F., Hidalgo, A. & Teixidó, J. Chemokine stromal cell-derived factor-1 α modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. Blood97, 346–351 (2001). ArticlePubMed Google Scholar
Vacca, A. et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood93, 3064–3073 (1999). ArticleCASPubMed Google Scholar
Padró, T. et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood95, 2637–2644 (2000). ArticlePubMed Google Scholar
Lagneaux, L., Delforge, A., Bron, D., De Bruyn, C. & Styckmans, P. Chronic lympocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood91, 2387–2396 (1998). ArticleCASPubMed Google Scholar
Shain, K. H., Landowski, T. H. & Dalton, W. S. The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance. Curr. Opin. Oncol.12, 557–563 (2000). ArticleCASPubMed Google Scholar
Mudry, R. E., Fortney, J. E., York, T., Hall, B. M. & Gibson, L. F. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood96, 1926–1932 (2000). ArticleCASPubMed Google Scholar
Cheung, W.-C. & Van Ness, B. The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. Leukemia15, 264–271 (2001). ArticleCASPubMed Google Scholar
Moreno, A. et al. Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood97, 242–249 (2001). ArticleCASPubMed Google Scholar
Illmensee, K. & Mintz, B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl Acad. Sci. USA73, 549–553 (1976).Malignant mouse teratocarcinoma cells, grown through 200 transplant generations over 8 years asin vivoascites tumours, were microinjected into developing blastocysts. The resulting genetic mosaics were normal, and tumour cells were able to develop into normal tissues. ArticleCASPubMedPubMed Central Google Scholar
Dolberg, D. S. & Bissell, M. J. Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature309, 552–556 (1984). ArticleCASPubMed Google Scholar
Stoker, A. W., Hatier, C. & Bissell, M. J. The embryonic environment strongly attenuates _v_-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell Biol.111, 217–228 (1990). ArticleCASPubMed Google Scholar
Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res.59, 5002–5011 (1999).A direct demonstration of the interdependence of the tumour epithelium and the tumour-associated stromal cells. CASPubMed Google Scholar
Szabowski, A. et al. _c_-Jun and JunB antagonistically control cytokine-regulated mesenchymal–epidermal interaction in skin. Cell103, 745–755 (2000). ArticleCASPubMed Google Scholar
Javaherian, A., Vaccariello, M., Fusenig, N. E. & Garlick, J. A. Normal keratinocytes suppress early stages of neoplastic progression in stratified epithelium. Cancer Res.58, 2200–2209 (1998). CASPubMed Google Scholar
Barcellos-Hoff, M. H., Aggeler, J., Ram, T. G. & Bissell, M. J. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development105, 223–235 (1989). ArticleCASPubMed Google Scholar
Petersen, O. W., Ronnov-Jessen, L., Howlett, A. R. & Bissell, M. J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl Acad. Sci. USA89, 9064–9068 (1992). ArticleCASPubMedPubMed Central Google Scholar
Weaver, V. M. et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol.137, 231–245 (1997).Showed that progression to tumorigenicity in a mammary epithelial tumour-progression cell-culture model is accompanied by upregulation of β1-integrins, and that β1-blocking antibodies can restore normal phenotype and suppress tumorigenesis. ArticleCASPubMedPubMed Central Google Scholar
Wang, F. et al. Reciprocal interactions between β1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proc. Natl Acad. Sci. USA95, 14821–14826 (1998). ArticleCASPubMedPubMed Central Google Scholar
Wang, F., Yoneda, T., Barcellos-Hoff, M. H. & Bissell, M. J. Combinatorial modifications of multiple pathways reverts the malignant phenotype of mammary carcinoma cells MDA–MB231. Mol. Biol. Cell10, 2024 (1999). Article Google Scholar
Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med.344, 783–792 (2001). ArticleCASPubMed Google Scholar
Joensuu, H. et al. Effect of the tyrosine kinase inhibitor STI-571 in a patient with a metastatic gastrointestinal stromal tumor. N. Engl. J. Med.344, 1052–1056 (2001). ArticleCASPubMed Google Scholar
Friedman, S. L., Maher, J. J. & Bissell, D. M. Mechanisms and therapy of hepatic fibrosis. Hepatology32, 1403–1408 (2000). ArticleCASPubMed Google Scholar
Bilimora, M. M. et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch. Surg.136, 528–535 (2001). Article Google Scholar
Jacobs, T. W., Byrne, C., Colditz, G., Connolly, J. L. & Schnitt, S. J. Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N. Engl. J. Med.340, 430–436 (1999). ArticleCASPubMed Google Scholar
Mossman, B. T. & Churg, A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med.157, 1666–1680 (1998). ArticleCASPubMed Google Scholar
Bange, J., Zwick, E. & Ullrich, A. Molecular targets for breast cancer therapy and prevention. Nature Med.7, 548–552 (2001). ArticleCASPubMed Google Scholar
Oshima, M. et al. Suppression of intestinal polyposis in ApcΔ716 knockout mice by inhibition of prostaglandin endoperoxide synthase-2 (COX2). Cell, 87, 803–809 (1996). ArticleCASPubMed Google Scholar
Tsujii, M. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell93, 705–716 (1998). ArticleCASPubMed Google Scholar
Liu, C. H. et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem.276, 18563–18569 (2001). ArticleCASPubMed Google Scholar
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K. & DuBois, R. N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest.105, 1589–1594 (2000).Showed that the induction of angiogenesis depends uponCOX2expression within tumour-associated fibroblasts, rather than within the tumour itself. ArticleCASPubMedPubMed Central Google Scholar
Herbst, R. S., Lee, A. T., Tran, H. T. & Abbruzzese, J. L. Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center trial of human endostatin. Curr. Curr Oncol Rep3, 131–140 (2001). ArticleCASPubMed Google Scholar
Zucker, S., Cao, J. & Chen, W.T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene19, 6642—6650 (2000).
Hidalgo, H. & Eckhart, S. G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl Cancer Inst.93, 178–193 (2001). ArticleCASPubMed Google Scholar
Reichmann, E. Oncogenes and epithelial cell transformation. Semin. Cancer Biol.5, 157–165 (1994). CASPubMed Google Scholar
Bilder, D., Li, M. & Perrimon, N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science289, 113–116 (2000).A genetic screen to identify proteins that mediate epithelial polarity inDrosophilaidentified a network of two known tumour suppressors and a new gene that are involved in the assembly and maintenance of gap junctions. ArticleCASPubMed Google Scholar
Bilder, D. & Perrimon, N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature403, 676–680 (2000). ArticleCASPubMed Google Scholar
Borg, J. P. et al. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nature Cell Biol.2, 407–414 (2000). ArticleCASPubMed Google Scholar
Singer, A. J. and Clark, R. A. Cutaneous wound healing. N. Engl. J. Med.341, 738–746 (1999). ArticleCASPubMed Google Scholar
Skobe, M. & Fusenig, N. E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl Acad. Sci. USA.95, 1050–1055 (1998). ArticleCASPubMedPubMed Central Google Scholar
Blobe, G. C., Schiemann, W. P. & Lodish, H. F. Role of transforming growth factor β in human disease. N. Engl. J. Med.342, 1350–1358 (2000). ArticleCASPubMed Google Scholar
Ronnov-Jessen, L., Petersen, O. W., Koteliansky, V. E. & Bissell, M. J. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J. Clin. Invest.95, 859–873 (1995). ArticleCASPubMedPubMed Central Google Scholar
Okamoto-Inoue, M., Kamada, S., Kimura, G. & Taniguchi, S. The induction of smooth muscle α-actin in a transformed rat cell line suppresses malignant properties in vitro and in vivo. Cancer Lett.142, 173–178 (1999). ArticleCASPubMed Google Scholar
Zajchowski, D. A. et al. Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells. Proc. Natl Acad. Sci. USA87, 2314–2318 (1990). ArticleCASPubMedPubMed Central Google Scholar
Sager, R., Anisoxicz, A., Neveu, M., Liang, P. & Sotiropoulou, G. Identification by differential display of α6-integrin as a candidate tumor suppressor gene. FASEB J.7, 964–970 (1993). ArticleCASPubMed Google Scholar
Lee, S. W., Reimer, C. L., Oh, P., Campbell, D. B. & Schnitzer, J. E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene16, 1391–1397 (1998). ArticleCASPubMed Google Scholar
Hirshi, K. K., Xu, C., Tsukamoto, T. & Sager, R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ.7, 861–870 (1996). Google Scholar
Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science, 263, 526–529 (1994). ArticleCASPubMed Google Scholar
Bani, D., Riva, A., Bigazzi, M. & Sacchi, B. T. Differentiation of breast cancer cells in vitro is promoted by the concurrent influence of myoepithelial cells and relaxin. Br. J. Cancer70, 900–904 (1994). ArticleCASPubMedPubMed Central Google Scholar
Liu, Q. Y. et al. Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res.56, 1155–1163 (1996). CASPubMed Google Scholar